SUMMARY OF STOCK OPTION ACTIVITY (Details) - $ / shares |
6 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 13, 2025 |
Jun. 11, 2025 |
Apr. 16, 2025 |
Jan. 14, 2025 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Equity [Abstract] | ||||||
| Number of shares, outstanding beginning balance | 26,705,000 | 17,380,000 | ||||
| Number of shares outstanding, granted | 11,560,000 | |||||
| Number of shares outstanding, forfeited | (1,000,000) | (840,000) | (4,805,000) | (1,395,000) | (4,805,000) | (2,235,000) |
| Number of shares, outstanding ending balance | 21,900,000 | 26,705,000 | ||||
| Options outstanding weighted-average contractual life in years | 8 years 1 month 6 days | 8 years 7 months 28 days | ||||
| Weighted-average exercise price exercisable | $ 0.0743 | $ 0.0663 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares (or other type of equity) forfeited during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|